Vismodegib Impurity 6
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2117637-61-1Vismodegib Impurity 6

● In Stock

Catalogue No.:VE0028237
CAS No.:2117637-61-1
Mol. Formula:C19H15ClN2O3S
Mol. Weight:386.85 g/mol

Additional information on CAS 2117637-61-1

Parent drug

Vismodegib

IUPAC Name

2-Chloro-4-(methylsulfonyl)-N-(3-(pyridin-2-yl)phenyl)benzamide

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

CS(C1=CC=C(C(NC2=CC=CC(C3=NC=CC=C3)=C2)=O)C(Cl)=C1)(=O)=O

InChI

InChI=1S/C19H15ClN2O3S/c1-26(24,25)15-8-9-16(17(20)12-15)19(23)22-14-6-4-5-13(11-14)18-7-2-3-10-21-18/h2-12H,1H3,(H,22,23)

Description

Vismodegib Impurity 6 (CAS 2117637-61-1) is a characterized process-related impurity encountered during Vismodegib synthesis, exhibiting distinct chromatographic retention and diagnostic mass spectral fragments that support sensitive detection by HPLC-UV and LC-MS and structural confirmation by NMR. Control strategies typically target qualification at low ppm levels with acceptance criteria aligned to ICH impurity guidelines to protect drug substance quality and stability. Key analytical attributes include retention time, exact mass, and fragmentation pattern for routine monitoring, while forced-degradation and stability studies help define its formation pathways, storage conditions, and measures to minimize batch-to-batch variability.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url